Sarepta hires CEO effective July 2026
Sarepta Therapeutics announced a new employment agreement with Michael Severino M.D. effective July 28, 2026, to serve as the company's Chief Executive Officer and Board member. This move signals a planned leadership transition and serves to provide continuity for the biopharmaceutical company's strategic direction.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day